The interleukins in acquired disease.
- 1 November 1988
- journal article
- review article
- Vol. 74 (2) , 151-61
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- Pathogenesis of Infection with Human Immunodeficiency VirusNew England Journal of Medicine, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Immunological discrimination between self and non-self by precursor depletion and memory accumulationJournal of Theoretical Biology, 1987
- Acquired Defect in Interleukin-2 Production in Patients with Type I Diabetes MellitusNew England Journal of Medicine, 1986
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- REDUCED EXPRESSION OF INTERLEUKIN-2 RECEPTORS IN HYPOGAMMAGLOBULINAEMIA: A POSSIBLE CAUSE OF HIGHER CANCER INCIDENCEThe Lancet, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985